Maze Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $10.98-$53.65 |
Market Cap | $1.4B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $20M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $20M |
Diluted EPS | -$2.35 |
News
See moreYahoo Finance • last month
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
Yahoo Finance • last month
Maze Therapeutics GAAP EPS of -$0.45 beats by $0.10, revenue of $20M beats by $11.5M
Yahoo Finance • 2 months ago
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
Yahoo Finance • 2 months ago
What Makes Maze Therapeutics (MAZE) One of the Best Oversold Small-Cap Stocks to Buy
About
CEO | Dr. Jason V. Coloma M.B.A., M.P.H., Ph.D. |
CFO | Mr. Misbah Tahir CPA |
Address | 171 Oyster Point Blvd, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |